
Deep Breath Intelligence (DBI) is a MedTech company focused on the potential of breath metabolomics, utilizing advanced data science and cutting-edge technologies. Founded in 2018 and headquartered in Rotkreuz, Switzerland, DBI develops science and evidence-backed solutions for disease detection and personalized health management for healthcare providers and health-conscious individuals. Their technology has been developed in collaboration with research institutions like the University of Basel, ETH Zurich, Yale University, and the University of Zurich. DBI offers a unique portfolio of software and hardware to advance non-invasive breath analysis across various medical fields. They are currently updating their website with new products and services.

Deep Breath Intelligence (DBI) is a MedTech company focused on the potential of breath metabolomics, utilizing advanced data science and cutting-edge technologies. Founded in 2018 and headquartered in Rotkreuz, Switzerland, DBI develops science and evidence-backed solutions for disease detection and personalized health management for healthcare providers and health-conscious individuals. Their technology has been developed in collaboration with research institutions like the University of Basel, ETH Zurich, Yale University, and the University of Zurich. DBI offers a unique portfolio of software and hardware to advance non-invasive breath analysis across various medical fields. They are currently updating their website with new products and services.
Headquarters: Rotkreuz (Zug), Switzerland
Founded: 2018
Focus: Non-invasive breath metabolomics (HRMS + machine learning)
Flagship product: DBI-EPIbreath — CE‑IVD (2022) for valproate therapeutic drug monitoring
Funding: Seed round announced 2022-07-25; total funding reported USD 2,800,000
Team size (reported): 4 employees
Breath-based diagnostics and monitoring, including therapeutic drug monitoring and chronic disease monitoring through breath metabolomics.
2018
MedTech
2800000.00 USD
“Founder/co-founder investors are involved; investor/support listings include Swissnex and the University of Basel in investor-related entries.”